首页> 外文期刊>American Journal of Physiology >ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo.
【24h】

ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo.

机译:ET-1在体内通过激活ETA受体/磷脂酶C途径诱导皮质扩散抑制。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recently, it has been shown that brain topical superfusion of endothelin (ET)-1 at concentrations around 100 nM induces repetitive cortical spreading depressions (CSDs) in vivo. It has remained unclear whether this effect of ET-1 is related to a primary neuronal/astroglial effect, such as an increase in neuronal excitability or induction of interastroglial calcium waves, or a penumbra-like condition after vasoconstriction. In vitro, ET-1 regulates interastroglial communication via combined activation of ET(A) and ET(B) receptors, whereas it induces vasoconstriction via single activation of ET(A) receptors. We have determined the ET receptor profile and intracellular signaling pathway of ET-1-induced CSDs in vivo. In contrast to the ET(B) receptor antagonist BQ-788 and concentration dependently, the ET(A) receptor antagonist BQ-123 completely blocked the occurrence of ET-1-induced CSDs. The ET(B) receptor antagonist did not increase the efficacy of the ET(A) receptor antagonist. Direct stimulation of ET(B) receptors with the selective ET(B) agonist BQ-3020 did not trigger CSDs. The phospholipase C (PLC) antagonist U-73122 inhibited CSD occurrence in contrast to the protein kinase C inhibitor Go-6983. Our findings indicate that ET-1 induces CSDs through ET(A) receptor and PLC activation. We conclude that the induction of interastroglial calcium waves is unlikely the primary cause of ET-1-induced CSDs. On the basis of the receptor profile, likely primary targets of ET-1 mediating CSD are either neurons or vascular smooth muscle cells.
机译:最近,已经显示脑外用内皮素(ET)-1的浓度约为100 nM会在体内诱导重复性皮质扩散抑制(CSD)。尚不清楚ET-1的这种作用是否与原发性神经元/星形胶质细胞作用有关,例如神经元兴奋性的增加或星形胶质细胞内钙波的诱导,或血管收缩后的半影状病症。在体外,ET-1通过ET(A)和ET(B)受体的联合激活来调节星形胶质细胞间的通讯,而通过ET(A)受体的单次激活来诱导血管收缩。我们已经确定了ET-1诱导的CSD在体内的ET受体概况和细胞内信号传导途径。与ET(B)受体拮抗剂BQ-788和浓度依赖性不同,ET(A)受体拮抗剂BQ-123完全阻断了ET-1诱导的CSD的发生。 ET(B)受体拮抗剂没有增加ET(A)受体拮抗剂的功效。用选择性ET(B)激动剂BQ-3020直接刺激ET(B)受体不会触发CSD。与蛋白激酶C抑制剂Go-6983相比,磷脂酶C(PLC)拮抗剂U-73122抑制CSD的发生。我们的发现表明,ET-1通过ET(A)受体和PLC激活诱导CSD。我们得出结论,星形胶质间钙波的诱导不太可能是ET-1诱导的CSD的主要原因。根据受体概况,介导ET-1的CSD的主要靶标可能是神经元或血管平滑肌细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号